This study assesses the effectiveness of pars plana vitrectomy in treating uveal effusion syndrome in six patients who underwent various surgical procedures, including internal drainage and photocoagulation.
All cases resulted in retinal reattachment, but complications were noted in the nanophthalmic cases, including the need for additional surgery and one case of subchoroidal hemorrhage.
The findings suggest that vitrectomy is beneficial for non-nanophthalmic uveal effusion, enhancing visual outcomes, whereas nanophthalmic cases may require sclerostomy as a preliminary step.
The study assessed the effectiveness of intravitreal gas injection for treating submacular hemorrhages (SMH) in 29 patients.
Results showed that within five days of treatment, most patients experienced movement of the hemorrhage, and 79% achieved improved visual acuity after six months.
The procedure often reduced the need for vitrectomy and had no serious complications, making it a viable first-choice treatment option for SMH.
The study aimed to assess the quality of life related to vision in patients who had vitrectomy for diabetic retinopathy, utilizing the Japanese version of the NEI VFQ-25 questionnaire.
It involved 87 patients, with data collected one month before and six months after the surgery, and compared the results by different eye conditions.
Results showed significant improvements in nearly all quality of life subscales, particularly for patients with vitreous hemorrhage, suggesting vitrectomy effectively enhances visual quality of life for those with diabetic retinopathy.